The Report Digital Pathology Market Size, Share & Trends Analysis Report By Application
(Drug Discovery & Development, By Product, Academic Research, Diagnosis),
By End Use, And Segment Forecasts, 2019 – 2026
The global digital pathology market size
is expected to reach USD 1.67 billion by 2026, according to a new report by
Grand View Research, Inc. It is anticipated to expand at a CAGR of 11.7% during
the forecast period. Increasing prevalence of chronic diseases triggers the
demand for advanced diagnostics, which is expected to drive the market growth.
Growing economic stability and awareness pertaining to the benefits with the
use of computer-aided diagnostics is further contributing to the growth.
Technological
advancements such as digital imaging, computerization, robotic light microscopy,
and multiple fiberoptic communications are some of the key factors driving the
adoption of digital pathology. In addition, introduction of cloud-based
technology enabling storage of digital slides coupled with secure access to
pathologists is expected to serve as a potential growth driver for the market.
Digital
pathology has important role in companion diagnostics and drug development
pipeline, including molecular biology, biobanking, molecular tissue profiling,
and tissue microarray analysis. Increasing demand for high-quality tissue
samples in tissue-based biomarker research is expected to propel adoption of
the technology over the forecast period.
The
market is expected to witness intense competition in near future owing to
rising adoption of rigorous strategies by the market players to sustain
competition. For instance; whole slide imaging system manufacturers focus on
obtaining premarket approval for diagnostic digital systems to capture greater
revenue share.
Further key findings
from the study suggest:
· Devices held the dominant market share in 2018 owing to
increased use in academic research
· Rising implementation of slide management system in
stratified medicine and tissue-based biomarker research is one of the key
contributing factors for the dominance of this technology
· Software segment is expected to witness lucrative growth
in near future as the product assists in faster diagnosis and synchronization
of patient data, where healthcare professionals can remotely access this
information
· Digital pathology is increasingly used in academic
research owing to various benefits such as cost-effectiveness and rapid results
· Disease diagnosis segment is expected to witness
lucrative growth over the forecast period owing to the increasing prevalence of
cancer and demand for noble diagnosis techniques
· Availability of unified platforms for workflows in
pathology is anticipated to boost the usage of computer-aided imaging
technology in academic research, which is anticipated to boost the segment
growth
· Hospital led the end use segment in 2018 owing to the
increasing adoption of these technologies across these facilities
Grand View Research has segmented the global digital
pathology market on the basis of the product, application, end use, and region:
Digital Pathology
Product Outlook (Revenue, USD Million, 2014 - 2026)
·
Software
·
Device
o Scanners
o Slide
Management System
·
Storage System
Digital Pathology
Application Outlook (Revenue, USD Million, 2014 - 2026)
·
Drug Discovery & Development
·
Academic Research
·
Disease Diagnosis
o Cancer
Cell Detection
o Others
Digital Pathology End
Use Outlook (Revenue, USD Million, 2014 - 2026)
·
Hospitals
·
Diagnostic Labs
·
Biotech & Pharma Companies
·
Academic & Research Institutes
Digital Pathology
Regional Outlook (Revenue, USD Million, 2014 - 2026)
·
North America
o U.S.
o Canada
·
Europe
o U.K.
o Germany
o Italy
o France
o Russia
o Spain
o Netherlands
o Switzerland
o Sweden
·
Asia Pacific
o Japan
o China
o India
o Indonesia
o Thailand
o Australia
o South
Korea
o Philippines
o Malaysia
o Singapore
·
Latin America
o Mexico
o Brazil
o Argentina
·
MEA
o South
Africa
o Saudi
Arabia
o Turkey
o Iran
o UAE
o Israel
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
